The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 18, 2020
Filed:
Oct. 09, 2015
Applicants:
Ablynx N.v., Ghent-Zwijnaarde, BE;
Vectura Gmbh, Gauting, DE;
Inventors:
Koen Allosery, Ostend, BE;
Erik Depla, Destelbergen, BE;
Martin Huber, Gauting, DE;
Tobias Kolb, Gauting, DE;
Bernhard Müllinger, Gauting, DE;
Massimiliano Germani, Geel, BE;
Juliane Schick, Gauting, DE;
Maria-Laura Sargentini, Brussels, BE;
Assignees:
ABLYNX N.V., Ghent-Zwijnaarde, BE;
VECTURA GMBH, Gauting, DE;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/42 (2006.01); A61M 15/00 (2006.01); A61K 9/00 (2006.01); A61M 15/02 (2006.01); C07K 16/10 (2006.01); A61K 45/06 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61M 15/002 (2014.02); A61K 9/0078 (2013.01); A61K 39/42 (2013.01); A61K 45/06 (2013.01); A61M 15/009 (2013.01); A61M 15/0021 (2014.02); A61M 15/025 (2014.02); C07K 16/10 (2013.01); C07K 16/1027 (2013.01); A61K 2039/505 (2013.01); A61K 2039/54 (2013.01); A61K 2039/545 (2013.01); A61M 2202/025 (2013.01); A61M 2202/0208 (2013.01); A61M 2202/0266 (2013.01); A61M 2206/11 (2013.01); A61M 2240/00 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/567 (2013.01); C07K 2317/569 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01);
Abstract
Methods are provided for the treatment of RSV infections in young children. More specifically, methods are provided wherein polypeptides that bind F protein of hRSV and that neutralize RSV infection are administered to the lungs of young children at specific dose regimens.